信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·国办印发《中医药振兴发展重大工程实施方案》2023-2-28 17:14:58
·巨丰复盘:沪指午后V型反转医药股强势上涨2023-2-28 16:32:52
·创新药概念走势活跃吉贝尔大涨超18%去年净利润同比增约34%2023-2-28 16:30:11
·复盘35只涨停股:数字政通炸板众合科技2连板特一药业首板2023-2-28 16:29:49
·发生了什么?突然狂拉:多股涨停!医药板块异动拉升九牧王实现3连板2023-2-28 16:29:05
·巨丰收评:大盘午后反转医药股强势上行2023-2-28 16:20:24
·悦康药业2022年度净利3.38亿同比减少38.05%运营成本增加2023-2-28 15:07:19
·热点调查|“韭菜王”云南白药跨界医美,还能再创奇迹吗?2023-2-28 15:07:12
·A股三大指数集体收涨中药板块涨幅居前2023-2-28 15:07:05
·政策利好发酵!中药股集体大爆发医药赛道整体修复这三大亮点或成主线2023-2-28 14:31:50
·柳药集团2022年度净利6.92亿同比增长22.79%零售业务稳健增长2023-2-28 13:51:14
·南新制药2022年度亏损1817.68万同比亏损减少销售费用下降2023-2-28 12:29:34
·抗癌神药ADC成抢手货,辉瑞或砸300亿美元收购Seagen,国产药物掀起出海潮2023-2-28 11:26:33
·甲流疫情抬头流感神药、疫苗接种热度升温市场供应暂无虞2023-2-28 10:19:24
·海创药业2022年度亏损3.02亿同比亏损减少公司研发的多个创新药物项目持续稳步推进中2023-2-28 0:57:05
·峆一药业2022年净利润5644万元:同比增长69%优化工艺技术2023-2-27 21:21:04
·宣泰医药2022年度净利9294.15万同比下滑31.11%权益分成收入下滑明显2023-2-27 20:51:52
·力生制药2022年度净利9340.42万同比减少23.51%完成了子公司资产处置2023-2-27 20:22:41
·北陆药业董事长恢复中国国籍,去年曾被投资者提问为何迟迟不能成为中国国籍2023-2-27 18:26:25
·拓新药业:多名股东拟合计减持不超6%2023-2-27 18:09:19

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]